Difference between revisions of "NextGen-O2k Exploitation"
From Bioblast
Beno Marija (talk | contribs) |
Beno Marija (talk | contribs) |
||
| Line 29: | Line 29: | ||
File:JP Onsite.jpg|On-site visit in Japan | File:JP Onsite.jpg|On-site visit in Japan | ||
File:ORODM1A.jpg|The first Distributor Meeting | File:ORODM1A.jpg|The first Distributor Meeting | ||
File:ASMRM & J-mit 2019 Fukuoka JP.jpeg|The Oroboros booth at the ASMRM & J-mit 2019 | |||
|- | |- | ||
</gallery> | </gallery> | ||
Revision as of 08:47, 20 May 2020
Template:MitoFit highlights page name
The revolutionary all-in-one instrument to conquer mitochondrial disease.
WP4: Exploitation
Abstract
- Preparation for a successful market launch of the NextGen-O2k.
Progress and next steps
- 2020-02-04: Our Mitochondrial Wizard Luiza Daltro Cardoso, PhD went to Japan to meet our distributor and teach him high-resolution respirometry combined with H2O2, mt-membrane potential and ATP production measurements: Distributor engagement Tokyo JP
- 2020-10-03: Erich Gnaiger travels to Fukuoka to attend J-Mit and ASMRM 2019 and meet our distributor Berthold Japan K.K.
- 2019-07-01: The first Distributor Meeting took place, see more: Oroboros Distributor Meeting
Snapshot of the J-Mit and ASMRM 2019
On-site visit in Japan
The first Distributor Meeting
The Oroboros booth at the ASMRM & J-mit 2019
